The novel, broad-spectrum antitumor antibiotics, 720) and PD 114,721 are components of bioactive compounds produced by a novel actinomycete (ATCC 39366). The organism is unique in that whole cell analysis revealed LL-diaminopimelic acid and major amounts of arabinose.
The novel, broad-spectrum antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721 are components of bioactive compounds produced by a novel actinomycete (ATCC 39366). The organism is unique in that whole cell analysis revealed LL-diaminopimelic acid and major amounts of arabinose.
These new antibiotics exhibit potent antitumor activity in vitro and in vivo versus an array of tumors and possess strong antibacterial and antifungal activity.
The above antibiotics are produced in 7,570-liter fermentors at yields of 5 ~ 8 ug/ml.
During the course of our antitumor antibiotic drug discovery program, the fermentation broth of actinomycete isolate WP-2053 was found active vs. L1210 murine leukemic cells in vitro. The producing organism was identified as a novel actinomycete and deposited with the American Type Culture Collection (Rockville, Md) as ATCC 39366.
The biological activity found in the fermentation broth was attributed to a complex of compounds. The two major components of the complex were isolated and identified as CI-940 (PD 114,720) and PD 114,721 (Fig. 1) . Structural studies on these two compounds were carried out by SCHAUMBERG et al.1).
This paper describes the taxonomy of the producing organism and fermentation and biological aspects of the two compounds. 
Culture Isolation and Characterization
The culture was isolated from a soil sample collected in East Greenville, PA. The plating medium consisted of 3 % glycerol, 0.25% L-asparagine, 0.05% KCl, 0.05% MgSO4.7H2O, 0.001 % FeSO4.7H2O, 0.1% K2HPO4 and 1.5% agar.
Culture characterization was carried out following the ISP (International Streptomyces Project) procedure2). The culture was maintained on Amidex Corn Starch Agar ADX3) slants at 24°C. Morphological and color determinations of the growth of the organism were made at weekly intervals over a six-week period. Purified cell walls and whole cell hydrolysates were analyzed following the methods of BECKER et al.4) and LECHEVALIER8), respectively. Fermentation Stock cultures of the organism were maintained in lyophilized vials, and working cultures stored as cryovials in liquid nitrogen refrigerator (Union Carbide, Indianapolis). To start a fermentation, the contents of a thawed cryovial was used to inoculate a 300-ml seed flask containing 50 ml of seed medium. The inoculated flask was incubated with shaking (New Brunswick Shaker, 5-cm throw) at 24°C for 2 3 days. The seed medium consisted of: 0. For HPLC assay, 5-ml of fermentation broth was acidified with 0.15 ml of 1 N HCl; 5 ml EtOAc was added, mixed thoroughly, then centrifuged for 10 minutes 450 x g (International Clinical Centrifuge, Boston, Mass.). The EtOAc layer was recovered, reduced to dryness then reconstituted in 0.5 ml methanol; 10 ul was chromatographed over a , uBondapak C18 silica gel column (Waters Associates, Milford, Mass.), at a flow rate of 1.5 ml/minute using 0.05 M ammonium acetate buffer (pH 6.5) -acetonitrile (45: 55) solvent system. The retention time for PD 114,720 was 5.45 minutes and 4.0 minutes for PD 114,721.
The in vivo antitumor activity was evaluated vs. P388 murine lymphocytic leukemic and L1210 murine lymphoid leukemia tumor cell lines in CDF mice5). The tumor cells were injected intraperitoneally (ip) on day 0 and the compounds were also introduced ip on days 1 ~ 9.
Results

Morphological and Cultural Characteristics
Isolate WP-2053 was identified as a member of the Grey series of actinomycetes, Table 1 . The spores were produced in a spiral chain with 10 or more spores in a chain (Fig. 2) . The spores were smooth and cylindrical or rectangular in shape (Fig. 3) .
Cell Wall and Whole Cell Sugar Analysis
The cell wall of isolate WP-2053 contained LL-diaminopimelic acid, and glycine which are characteristic of type I cell wall. A unique feature of the organism was the presence of a major amount of arabinose on whole cell analysis.
Physiological Characteristics
The isolate was found to reduce nitrate, liquefy gelatin, and peptonize skim milk. Melanin or other soluble pigments were not formed. The culture utilized 10 of the 16 carbons tested; it did not utilize arabinose, inulin, lactose, maltose, mannitol and sucrose (Table 2) .
Antitumor Activity PD 114,720 and PD 114,721 showed excellent activities vs. L1210 cell line in vitro : ID50 of 0.12 and 0.19 ng/ml, respectively. The activities vs. L1210 and P388 murine leukemias in vivo are shown in Table 3 . The bulk of our data, not reported here, indicates that doses > 0.1 mg/kg are toxic in the described treatment schedule. A detailed description of the antitumor activities in other tumor systems is reported in a separate communication6) .
Antimicrobial Activity
The compounds were both active vs. bacteria and fungi (Table 4) . PD 114,720 and PD 114,721
showed the same pattern of activity, although PD 114,721 was overall less potent. 
Fermentation
The initial shake flask medium (SF) which gave trace amount of the complex consisted of 1.5% sucrose, 1.0% lactose, 0.65% peptonized milk (Humko-Sheffield, Ill.), 0.35% fish meal (Zapata Haynie, Md.), and 0.25% torula yeast (Lake States, Wis.). The fermentation broth at a dilution of 1: 1,000 inhibited 98% of L1210 growth in vitro.
Fermentation development was subsequently carried out and a final production medium (PM)
consisting of the following ingredients was developed : 1.5% maltose, 1.0% glucose, 0.75 % Pharmamedia, 0.4% corn meal and 0.25% torula yeast.
As shown in Table 5 , the production of PD 114,720 and PD 114,721 was higher in the PM than in the SF medium. The production of the antibiotics started about 24 hours after inoculation and peak yields were obtained after 96 hours (Fig. 4) . The yields of PD 114,720 and PD 114,721 in the 7,570-liter fermentor were 7.6 and 6.2 ug/ml, respectively. 
